Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. NTHI
NTHI logo

NTHI

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

NTHI News

NeOnc Technologies to Host Investor Conference Call on March 4, 2026

Feb 27 2026Newsfilter

New Show to Air Tonight on Bloomberg Television

Feb 21 2026Yahoo Finance

New Show Airing on Bloomberg Television

Feb 07 2026Yahoo Finance

NeOnc Secures $16 Million PIPE Investment for CNS Cancer Therapies

Jan 30 2026Newsfilter

New to The Street Highlights Blockchain and Oncology Innovations in Episode #710

Dec 27 2025Yahoo Finance

NeOnc's NEO100 Therapy Significantly Increases Survival Rates

Dec 15 2025Globenewswire

NeOnc Technologies Reports 24% Radiographic Response with NEO100 in CNS Cancer Trials

Dec 15 2025Newsfilter

NeOnc Technologies' NEO100 Therapy Shows Significant Antitumor Enhancement with Ultrasound

Dec 01 2025Newsfilter

NuroMENA, a Subsidiary of NeOnc Technologies, Enters Master Services Agreement with M42's IROS and Expands Its Board of Directors

Oct 09 2025Newsfilter

NeOnc Technologies Appoints Dr. Alexandra M. Miller, Chief of Neuro-Oncology at NYU Langone Health's Perlmutter Cancer Center, to Its Scientific Advisory Board

Oct 01 2025Newsfilter

NeOnc Technologies to Present Brain Cancer Advances to 63 Million TV Viewers on "Health Uncensored with Dr. Drew" Airing Nationwide on Lifetime Network September 25 at 8:00 a.m. ET/PT

Sep 22 2025Newsfilter

Blue Gold Names Sameer Salgar of Quazar to Advisory Board to Strengthen UAE Connections and Shape Digital Gold Strategy

Sep 10 2025Newsfilter

NeOnc Technologies Completes Strategic Acquisition of Advanced AI and 3D Bioprinting Intellectual Property, Welcoming Esteemed Scientist Dr. Ishwar K. Puri to Its Board

Aug 25 2025Newsfilter

NeOnc Technologies Holdings Announces Q2 2025 Financial Results and Operational Insights

Aug 19 2025Newsfilter

NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer

Aug 04 2025Newsfilter

NeOnc Technologies' Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET

Jul 23 2025Newsfilter